Ameritas Investment Partners, Inc. - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 133 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2018. The put-call ratio across all filers is 0.63 and the average weighting 1.3%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$737,000
+8.4%
4,881
+4.5%
0.03%
+13.8%
Q2 2022$680,000
+31.8%
4,672
+7.4%
0.03%
+52.6%
Q1 2022$516,000
-14.0%
4,3510.0%0.02%
-5.0%
Q4 2021$600,000
-0.7%
4,3510.0%0.02%
-9.1%
Q3 2021$604,000
+47.0%
4,351
+2.7%
0.02%
+46.7%
Q2 2021$411,000
+49.5%
4,236
+5.1%
0.02%
+50.0%
Q1 2021$275,000
-20.3%
4,0300.0%0.01%
-37.5%
Q4 2020$345,000
+27.3%
4,030
-3.3%
0.02%
+33.3%
Q3 2020$271,000
-11.1%
4,1680.0%0.01%
-20.0%
Q2 2020$305,000
+158.5%
4,168
+20.5%
0.02%
+114.3%
Q1 2020$118,000
-37.2%
3,4600.0%0.01%
-12.5%
Q4 2019$188,000
+38.2%
3,460
+6.4%
0.01%
+33.3%
Q3 2019$136,000
+9.7%
3,252
+14.7%
0.01%0.0%
Q2 2019$124,000
-6.8%
2,834
+10.0%
0.01%0.0%
Q1 2019$133,000
+54.7%
2,576
+10.6%
0.01%
+20.0%
Q4 2018$86,000
-1.1%
2,3290.0%0.01%
+25.0%
Q3 2018$87,000
-5.4%
2,3290.0%0.00%0.0%
Q2 2018$92,000
+33.3%
2,329
-13.2%
0.00%
+33.3%
Q1 2018$69,000
+187.5%
2,682
+205.5%
0.00%
+200.0%
Q4 2017$24,000
-22.6%
8780.0%0.00%0.0%
Q3 2017$31,000
+40.9%
8780.0%0.00%0.0%
Q2 2017$22,0008780.00%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q4 2018
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 900,844$136,181,00079.57%
RP Management, LLC 1,111,111$167,967,00077.60%
JET CAPITAL INVESTORS L P 1,707,500$258,942,00053.95%
Alpine Global Management, LLC 373,999$56,537,00013.23%
Chicago Capital Management, LLC 154,585$23,443,00012.75%
FIFTH LANE CAPITAL, LP 140,000$21,164,00011.03%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 3,784,482$572,100,000,00010.85%
Eversept Partners, LP 637,139$96,316,3038.35%
EQUITEC PROPRIETARY MARKETS, LLC 187,100$28,284,0007.45%
HARVEST MANAGEMENT LLC 48,503$7,332,0005.92%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders